Warm autoimmune hemolytic anemia · 4 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Prednisolone and Rituximab Variant #01 Partial | — | R 103 728 | 84d | — | — | ~1 | ~R 103 728 indirect | — |
Prednisone and Rituximab Variant #01 Partial | — | R 51 848 | — | — | — | ~1 | ~R 51 848 indirect | — |
Prednisolone monotherapy Variant #03 Partial | — | R 109 | 84d | — | — | ~1 | ~R 109 PFS proxy · indirect | 1 |
Prednisone monotherapy Variant #11 | — | R 3 | 7d | ~2.2 mo | ~14.1 mo | ~1 | ~R 3 PFS proxy · indirect | 8 |
4 of 4 regimens shown